Searched for: +
(1 - 20 of 20)
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3
Adenoviral expression of a urokinase receptor - Targeted protease inhibitor inhibits neointima formation in murine and human blood vessels
Adenoviral expression of a urokinase receptor - Targeted protease inhibitor inhibits neointima formation in murine and human blood vessels
Cartilage invasion by rheumatoid synovial fibroblasts in vivo is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor: Abstract
Cartilage invasion by rheumatoid synovial fibroblasts in vivo is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor: Abstract
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor
Afbraak van kraakbeenmatrix door rheumatoïde synoviocyten wordt geremd door een membraan gebonden plasmine remmer via gentherapie
Afbraak van kraakbeenmatrix door rheumatoïde synoviocyten wordt geremd door een membraan gebonden plasmine remmer via gentherapie
Degradation of a cartilage-like matrix by rheumatoid synovial fibroblasts is inhibited by gene transfer with a cell surface-targeted plasmin inhibitor
Degradation of a cartilage-like matrix by rheumatoid synovial fibroblasts is inhibited by gene transfer with a cell surface-targeted plasmin inhibitor: abstract
Binding of human urokinase-type plasminogen activator to its receptor: Residues involved in species specificity and binding
Binding of human urokinase-type plasminogen activator to its receptor: Residues involved in species specificity and binding
The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by α2-macroglobulin receptor associated protein
The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by α2-macroglobulin receptor associated protein
Mitogenic effects of urokinase plasminogen activator (u-PA) on melanoma cell lines (abstract)
Mitogenic effects of urokinase plasminogen activator (u-PA) on melanoma cell lines (abstract)
Urokinase and tissue-type plasminogen activator stimulate human vascular smooth muscle cell migration
Urokinase and tissue-type plasminogen activator stimulate human vascular smooth muscle cell migration
In vitro invasive behavior of melanoma cells transfected with urokinase plasminogen activator mutants
In vitro invasive behavior of melanoma cells transfected with urokinase plasminogen activator mutants
The role of plasminogen activators in vascular pericellular proteolysis
The role of plasminogen activators in vascular pericellular proteolysis
Urokinase mediated, plasmin degradation of bone-like matrix
Urokinase mediated, plasmin degradation of bone-like matrix
Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha
Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha
Tissue-type plasminogen activator and its inhibitor in rat aorta: Effect of endotoxin
Tissue-type plasminogen activator and its inhibitor in rat aorta: Effect of endotoxin
Role of plasminogen activators and their inhibitor PAI-1 in pericellular proteolysis of smooth muscle cells and endothelial cells
Role of plasminogen activators and their inhibitor PAI-1 in pericellular proteolysis of smooth muscle cells and endothelial cells
Neue Gesichtspunkte der Melanompathogenese: Eigenschaften metastasierender und nicht-metastasierender humaner Melanomzellen
Neue Gesichtspunkte der Melanompathogenese: Eigenschaften metastasierender und nicht-metastasierender humaner Melanomzellen
Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis
Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis
Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines
Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo
Searched for: +
(1 - 20 of 20)